Skip to main content
Clinical Trials/NCT04980911
NCT04980911
Completed
Not Applicable

Iron Deficiency and Anemia in Cardiovascular Surgery

Centre Hospitalier Régional Metz-Thionville1 site in 1 country1,711 target enrollmentApril 12, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Anemia
Sponsor
Centre Hospitalier Régional Metz-Thionville
Enrollment
1711
Locations
1
Primary Endpoint
Number of transfusion
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Anemia and preoperative iron deficit in cardiac surgery are associated by an increased volume of transfusion and an increase in complications and/or mortality. Recent studies have shown that EPO and iron administration the days preceding the operation results in a reduction of perioperative transfusion for patients with preoperative anemia.

Registry
clinicaltrials.gov
Start Date
April 12, 2021
End Date
March 18, 2022
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Centre Hospitalier Régional Metz-Thionville
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient with cardiac surgery
  • With iron deficiency with or without anemia

Exclusion Criteria

  • Anemia without iron deficiency
  • Iron overload
  • Jehovah's witnesses
  • Endocarditis
  • Treating neoplasia
  • Uncontrolled hypertension
  • With infection
  • Alfa-epoetin hypersensitivity
  • Hypersensitivity of hamster's protein
  • Erythroblastopenia induced by erythropoietin

Outcomes

Primary Outcomes

Number of transfusion

Time Frame: Day 7

number of perioperative and post-operative transfusion

Secondary Outcomes

  • Number of post operative complications(Day 7)
  • Percentage of death(Day 7)

Study Sites (1)

Loading locations...

Similar Trials